UNSPSC 85572467: Supplement right main bronchus with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right main bronchus with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0BU347Z

UNSPSC 85572467 Supplement right main bronchus with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows no relevant recent state and local procurement activity. The five opportunities posted to the source between February and May 2026 — inmate medical and pharmacy services, pharmacy benefit management, virtual primary and urgent care, peer support for peer workers, and fire department medical direction — are all administrative healthcare service contracts or professional services engagements, none of which involve surgical implantation or tissue supplementation procedures. The code itself describes a specific surgical technique (supplementation of bronchial tissue using the patient's own cells via endoscopic approach), a clinical procedure typically procured by hospital systems or specialty medical centers through their materials management or clinical engineering functions rather than through competitive solicitation. The mismatch between the code's nominal scope and the healthcare-administration and service-delivery work actually appearing in recent state and local notices suggests that either the code is being applied to opportunities incorrectly by issuing bodies or the code itself does not map to routine state and local procurement activity.

The absence of relevant recent activity does not signal a prohibition on procurement under this code; hospitals, regional medical centers, and health systems do acquire implantable medical devices and consumables for surgical procedures. However, such acquisitions may be executed through standing group purchasing agreements, manufacturer direct contracts, or specialty medical supplier relationships rather than competitive RFPs. State and local procurement offices may also not tag surgical-supply acquisitions with this level of clinical specificity in their UNSPSC coding. Business development professionals should monitor vendor networks within hospital procurement and materials management; opportunities, when they arise, will likely originate from individual health systems or integrated delivery networks rather than general county or municipal purchasing offices.